SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001047469-15-005772
Filing Date
2015-06-25
Accepted
2015-06-25 16:44:13
Documents
5
Effectiveness Date
2015-06-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2225252zdefa14a.htm DEFA14A 19328
2 G147394BCI001.GIF g147394bci001.gif GRAPHIC 28653
3 G147394BCI002.GIF g147394bci002.gif GRAPHIC 58445
4 G147394BCI003.GIF g147394bci003.gif GRAPHIC 16856
5 G147394BCI004.GIF g147394bci004.gif GRAPHIC 2543
  Complete submission text file 0001047469-15-005772.txt   167799
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36306 | Film No.: 15952240
SIC: 2834 Pharmaceutical Preparations